Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 3

Risk reduction with clopidogrel in the management of peripheral arterial disease

Authors Keshav R Nayak, Jeffrey J Cavendish

Published 15 July 2007 Volume 2007:3(3) Pages 289—297

Download Article [PDF] 

Keshav R Nayak, Jeffrey J Cavendish

Department of Cardiology, Naval Medical Center San Diego, San Diego, CA, USA

Abstract: Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD.

Keywords: clopidogrel, antiplatelet therapy, peripheral artery disease

Download Article [PDF]